Opinion

Video

Acalabrutinib-Based Treatment Clinical Trial Updates

Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Image of man with brown hair.
Image of a man wearing a black button-up shirt.
Related Content
Illustration of woman with brown hair.
January 20th 2025

Waiting for Results After My CLL Diagnosis

Karen Cohn
Waiting for results of a CT scan after a cancer diagnosis is agonizing, as I anxiously await news on whether my disease has returned.
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
January 22nd 2024

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
Image of man with grey hair.
December 31st 2024

Preparing for Treatment: A Personal Reflection on Cancer

Andy Winnegar
As I prepare for treatment of my chronic lymphocytic leukemia, I reflect on the challenges of aging and side effects while staying focused on living fully.
CURE Talks Cancer podcast
December 31st 2020

The Treatment Journey of a Patient with CLL

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.
Image of a tumor cell in the bloodstream.
December 24th 2024

Top 4 Stories From the 2024 ASH Annual Meeting

Darlene Dobkowski, MA
CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple myeloma and other blood cancers.
Illustration of red blood cells.
December 23rd 2024

Epkinly Leads to Responses in Heavily Pretreated Patients With CLL

Gina Mauro
Among patients with heavily pretreated chronic lymphocytic leukemia, treatment with Epkinly monotherapy showed deep responses.